MDR1 variants and risk of Parkinson disease

被引:47
|
作者
Zschiedrich, Katja
Koenig, Inke R. [2 ]
Bruggemann, Norbert
Kock, Norman
Kasten, Meike
Leenders, Klaus L. [3 ]
Kostic, Vladimir [4 ]
Vieregge, Peter [5 ]
Ziegler, Andreas [2 ]
Klein, Christine [1 ]
Lohmann, Katja
机构
[1] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany
[2] Med Univ Lubeck, Inst Med Biometry & Stat, D-23538 Lubeck, Germany
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 AB Groningen, Netherlands
[4] Inst Neurol CCS, Sch Med, Belgrade, Serbia
[5] Clin Lippe Lemgo, Dept Neurol, Lemgo, Germany
关键词
MDR1; association; Parkinson disease; pesticides; interaction; SINGLE NUCLEOTIDE POLYMORPHISMS; P-GLYCOPROTEIN; PESTICIDE EXPOSURE; IN-VIVO; EXPRESSION; GENE; ASSOCIATION; TRANSPORTER; PATHOGENESIS; HAPLOTYPES;
D O I
10.1007/s00415-009-0089-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The multidrug resistance protein 1 (MDR1 or ABCB1) gene encodes a P-glycoprotein that protects the brain against neurotoxicants. Certain MDR1 genetic variants are known to compromise the function of this transporter and may thus be associated with Parkinson disease (PD). We therefore conducted a large case-control study investigating the potential relationship between MDR1 variants and PD. We determined the frequency of three MDR1 variants in 599 European PD patients and controls and further stratified the population by ethnicity, age at onset, and exposure to pesticides. We detected no relevant association in either the entire sample, or when separately investigating by ethnic origin or age at onset. However, the distribution of c.3435C/T differed significantly between PD patients exposed to pesticides compared to those non-exposed (odds ratio = 4.74; confidence interval = [1.009; 22.306]); p = 0.047), suggesting that common MDR1 variants might influence the risk to develop PD in conjunction with exposure to pesticides.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 50 条
  • [1] MDR1 variants and risk of Parkinson diseaseAssociation with pesticide exposure?
    Katja Zschiedrich
    Inke R. König
    Norbert Brüggemann
    Norman Kock
    Meike Kasten
    Klaus L. Leenders
    Vladimir Kostić
    Peter Vieregge
    Andreas Ziegler
    Christine Klein
    Katja Lohmann
    Journal of Neurology, 2009, 256 : 115 - 120
  • [2] MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysis
    Doxani, Chrysoula
    Voulgarelis, Michael
    Zintzaras, Elias
    BIOMARKERS, 2013, 18 (05) : 425 - 435
  • [3] Analysis of MDR1 haplotypes in Parkinson's disease in a white population
    Tan, EK
    Drozdzik, M
    Bialecka, M
    Honczarenko, K
    Klodowska-Duda, G
    Teo, Y
    Tang, K
    Wong, LP
    Chong, SS
    Tan, C
    Yew, K
    Zhao, Y
    Lee, CGL
    NEUROSCIENCE LETTERS, 2004, 372 (03) : 240 - 244
  • [4] Genetic Analysis of MDR1 and Inflammatory Bowel Disease Reveals Protective Effect of Heterozygous Variants for Ulcerative Colitis
    Huebner, Claudia
    Browning, Brian L.
    Petermann, Ivonne
    Han, Dug Yeo
    Philpott, Martin
    Barclay, Murray
    Gearry, Richard
    McCulloch, Alan
    Demmers, Pieter
    Ferguson, Lynnette R.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : 1784 - 1793
  • [5] Frequency of common MDR1 gene variants in a Polish population
    Kurzawski, M
    Pawlik, A
    Górnik, W
    Drozdzik, M
    PHARMACOLOGICAL REPORTS, 2006, 58 (01) : 35 - 40
  • [6] Association between MDR1 gene polymorphisms and Parkinson's disease in Asian and Caucasian populations: a meta-analysis
    Ahmed, Shiek S. S. J.
    Husain, R. S. Akram
    Kumar, Suresh
    Ramakrishnan, V.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 368 : 255 - 262
  • [7] Multidrug Resistance 1 (MDR1) Gene Polymorphisms in Childhood Drug-Resistant Epilepsy
    Alpman, Asude
    Ozkinay, Ferda
    Tekgul, Hasan
    Gokben, Sarenur
    Pehlivan, Sacide
    Schalling, Martin
    Ozkinay, Cihangir
    JOURNAL OF CHILD NEUROLOGY, 2010, 25 (12) : 1485 - 1490
  • [8] The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma
    Zmorzynski, Szymon
    Wojcierowska-Litwin, Magdalena
    Popek-Marciniec, Sylwia
    Szudy-Szczyrek, Aneta
    Styk, Wojciech
    Chocholska, Sylwia
    Filip, Agata Anna
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [9] Genetic polymorphisms of the multidrug resistance 1 gene MDR1 and the risk of hepatocellular carcinoma
    Wang, Zhi-Chao
    Liu, Long-Zi
    Liu, Xin-Yang
    Hu, Jin-Jing
    Wu, Yong-Na
    Shi, Jie-Yi
    Yang, Liu-Xiao
    Duan, Meng
    Wang, Xiao-Ying
    Zhou, Jian
    Fan, Jia
    Gao, Qiang
    TUMOR BIOLOGY, 2015, 36 (09) : 7007 - 7015
  • [10] MDR1 C3435T polymorphism and inflammatory bowel disease risk: a meta-analysis
    Wang, Jun
    Guo, Xufeng
    Yu, Shijie
    Zhang, Jixiang
    Song, Jia
    Ji, Mengyao
    Cao, Zhuo
    Wang, Jing
    Liu, Ya
    Dong, Weiguo
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (04) : 2679 - 2685